Welcome to Targeted Medical Pharma

Targeted Medical Pharma, a specialty pharmaceutical company, develops and commercializes proprietary nutrient pharmaceutical systems. Our therapeutic products target multiple diseases and disorders that encompass large patient populations.

We currently offer fourteen products that provide nutrient pharmaceutical systems with the lowest FDA approved doses of generic pharmaceuticals. Our current products manage pain syndromes, sleep disorders, asthma, hypertension, metabolic syndrome, and obesity. We have received approval for our first Investigation New Drug Application (“IND”) and are initiating Phase III clinical trials for the treatment of fibromyalgia and neurotoxicity syndromes which should lead to additional drug claims for the treatment of fibromyalgia and neurotoxicity syndromes.

We intend to continue to develop our technology and build a diverse portfolio of products that reduce side effects of drugs and provide targeted treatment for specific nutrient deficiencies associated with disease. Currently we distribute our products to physicians in the United States and to licensing partners in Japan and Poland.